What Chronicled does

Chronicled is a San Francisco-based, venture-backed private company founded in 2014 that builds blockchain and Web3 infrastructure specifically for the life sciences industry. The company operates a Web3-powered network with cryptographic integrity layers that enable pharmaceutical supply chain traceability, drug anti-counterfeiting, DSCSA compliance support, EU Falsified Medicines Directive alignment, clinical trial data management, and tamper-proof electronic health record handling. Its stated differentiators are domain specialization in life sciences and a regulatory-compliance-oriented architecture, rather than general-purpose blockchain tooling.

The company has raised approximately US$36.3 million in cumulative disclosed funding across multiple rounds between 2015 and February 2022, with the most recent round being a US$8.3 million financing led by True Global Ventures alongside an undisclosed Fortune 50 technology company as co-lead investor. Earlier rounds involved crypto-native and institutional investors including Pantera Capital, Colbeck Capital, Mandra Capital, Plug and Play, Iterative Capital Management, and R/GA Ventures. The company reports a headcount of 51-100 employees and is led by CEO Susanne Somerville alongside co-founders Maurizio Greco (CTO), Ryan Orr, and Dave Aho, with dedicated product, pharma solutions, and marketing leadership in place.

Chronicled's commercial model is not publicly disclosed: pricing, contract structures, customer logos, and revenue figures are not available in the source material. The company serves a single vertical — life sciences and pharmaceutical enterprises — and its go-to-market appears to be enterprise B2B, anchored by regulatory compliance use cases such as DSCSA traceability and anti-counterfeiting. Limited information is available on distribution channels, marketing channels, or partnership-driven go-to-market motions beyond the investor base. No disclosed products carry named SKUs, pricing tiers, or customer references in the available data.

Name

Chronicled

Website

https://chronicled.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Chronicled is a San Francisco-based, venture-backed company founded in 2014 that operates a Web3-powered blockchain network for the life sciences industry, providing pharmaceutical supply chain traceability, anti-counterfeiting, and DSCSA compliance solutions to pharmaceutical manufacturers, distributors, and related life sciences enterprises.

Ownership category

akta.pro rank

Product category

Pharmaceutical Supply Chain Software

NAICS

Security Systems Services (except Locksmiths) (561621)

SIC

Finance Services (6199)

akta.pro primary industry

Compliance, Risk & RegTech for Tokenized Assets (KYC/AML, sanctions, travel rule, reporting) (FSAPAIAH)

Keywords

• Blockchain supply chain
• Pharmaceutical traceability
• Drug anti-counterfeiting
• Life sciences blockchain
• DSCSA compliance software

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Core offering

Chronicled builds a Web3-powered blockchain network that delivers pharmaceutical supply chain traceability, anti-counterfeiting verification, electronic health records management, and clinical trial data integrity for the life sciences industry. Its platform provides cryptographic integrity layers aligned with regulatory frameworks such as DSCSA and the EU Falsified Medicines Directive, enabling pharmaceutical manufacturers, distributors, and healthcare organizations to maintain tamper-proof records across their supply chains.

Product overview

Chronicled is a Web3-powered network company operating in the life sciences industry, based in San Francisco. The company provides blockchain-based solutions for healthcare, including pharmaceutical supply chain traceability and data security applications. Specific named products or modules are not detailed in the available source material.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Emerging players

• OriginTrail: OriginTrail provides a blockchain-anchored knowledge graph for supply chain interoperability, including pharmaceutical and life sciences traceability use cases. It overlaps with Chronicled's cryptographic provenance capabilities while targeting a broader cross-industry audience.
• VeChain: VeChain is a public blockchain platform with deep focus on supply chain traceability across pharma, luxury, food, and logistics. It competes with Chronicled at the infrastructure layer for pharma traceability deployments and brings its own enterprise partnerships.

Direct peers

• Modum: Modum provides blockchain-based supply chain monitoring solutions, with a historical focus on pharmaceutical cold-chain compliance and DSCSA-style serialization. It is a direct functional peer to Chronicled in pharma-grade blockchain traceability.
• FarmaTrust: FarmaTrust uses blockchain and AI to combat counterfeit pharmaceuticals by tracking medicines through the supply chain. It is closely comparable to Chronicled in target customers (pharma manufacturers and regulators), use cases (anti-counterfeiting, provenance), and technology stack (enterprise blockchain).
• MediLedger: MediLedger is a blockchain-based network specifically designed for the pharmaceutical supply chain, offering DSCSA-compliant traceability and authentication. It directly competes with Chronicled on the same Web3-for-pharma value proposition and has run pilots with major wholesalers.
• Ambrosus: Ambrosus combines blockchain with IoT sensors to provide supply chain traceability and quality assurance for food and pharmaceutical products. It overlaps directly with Chronicled's pharma supply chain integrity offering, including anti-counterfeiting and provenance tracking.

Broad incumbents

• RFXCEL: RFXCEL (now part of Antares Vision) provides track-and-trace, serialization, and supply chain visibility software for the pharmaceutical industry. It serves the same regulatory-driven buyer base as Chronicled with a more traditional, enterprise-software approach.
• SAP (Pharma & Supply Chain solutions): SAP offers enterprise pharma supply chain, serialization, and traceability solutions as part of its broader ERP suite. It competes with Chronicled for the same regulated pharma buyers through established enterprise relationships and deep ERP integration.
• TraceLink: TraceLink is an established pharmaceutical serialization and supply chain traceability platform serving hundreds of manufacturers and CMOs globally. It is a broad incumbent serving the same DSCSA-driven buyer base as Chronicled, though it relies on traditional (non-blockchain) infrastructure.
• IBM Blockchain: IBM Blockchain, built largely on Hyperledger Fabric, underpins several pharma supply chain pilots and the broader IBM Food Trust model. It is a broad incumbent competing for the same enterprise blockchain-for-pharma workloads as Chronicled but as part of a much wider services portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/chronicledinc
• Facebookfacebook.com/chronicledinc
• LinkedInlinkedin.com/company/chronicled

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds10 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chronicled